RPGR-associated retinal degeneration in human X-linked RP and a murine model

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 9, 2012, Pages 5594-5608

  Huang, Wei Chieh ^a   Wright, Alan F ^b   Roman, Alejandro J ^a   Cideciyan, Artur V ^a   Manson, Forbes D ^b,e   Gewaily, Dina Y ^a   Schwartz, Sharon B ^a   Sadigh, Sam ^a   Limberis, Maria P ^c   Bell, Peter ^c   Wilson, James M ^c   Swaroop, Anand ^d   Jacobson, Samuel G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; FEMALE; GENE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA CONE; RETINA DEGENERATION; RETINA ROD; RETINITIS PIGMENTOSA GTPASE REGULATOR GENE; SOUTHERN BLOTTING; VISUAL ACUITY; ANIMAL; DISEASE MODEL; GENETICS; MIDDLE AGED; MOUSE MUTANT; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINITIS PIGMENTOSA; X CHROMOSOME LINKED DISORDER;

EYE PROTEIN; RPGR PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MUTATION; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL DEGENERATION; RETINAL ROD PHOTORECEPTOR CELLS; RETINITIS PIGMENTOSA; VISUAL ACUITY; YOUNG ADULT;

EID: 84867907906     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10070     Document Type: Article

References (59)

1. Bird AC. X-linked retinitis pigmentosa. Br J Ophthalmol. 1975; 59:177-199.
2. Wright AF. Towards the identification of genes in X-linked retinitis pigmentosa. Prog Ret Res. 1990;9:197-227.
3. Wright AF, Shu X. Focus on molecules: RPGR. Exp Eye Res. 2007;85:1-2.
4. Shu X, Black GC, Rice JM, et al. RPGR mutation analysis and disease: an update. Hum Mutat. 2007;28:322-328.
5. Sandberg MA, Rosner B, Weigel-DiFranco C, Dryja TP, Berson EL. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci. 2007;48:1298-1304.
6. Fahim AT, Bowne SJ, Sullivan LS, et al. Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations. PLoS One. 2011;6:e23021.
7. Cideciyan AV. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res. 2010;29:398-427.
8. Jacobson SG, Cideciyan AV, Ratnakaram R, et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9-24.
9. Veltel S, Wittinghofer A. RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa? Expert Opin Ther Targets. 2009;13:1239-1251.
10. Jacobson SG, Yagasaki K, Feuer WJ, Román AJ. Interocular asymmetry of visual function in heterozygotes of x-linked retinitis pigmentosa. Exp Eye Res. 1989;48:679-691.
11. Beltran WA, Cideciyan AV, Lewin AS, et al. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc Natl Acad Sci U S A. 2012;109:2132-2137.
12. Hong DH, Pawlyk BS, Shang J, Sandberg MA, Berson EL, Li T. A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci U S A. 2000;97:3649-3654.
13. Chang B, Hawes NL, Hurd RE, et al. Retinal degeneration mutants in the mouse. Vision Research. 2002;42:517-525.
14. Hong DH, Pawlyk BS, Adamian M, Li T. Dominant, gain-offunction mutant produced by truncation of RPGR. Invest Ophthalmol Vis Sci. 2004;45:36-41.
15. Brunner S, Skosyrski S, Kirschner-Schwabe R, et al. Cone versus rod disease in a mutant Rpgr mouse caused by different genetic backgrounds. Invest Ophthalmol Vis Sci. 2010;51: 1106-1115.
16. Wright RN, Hong DH, Perkins B. Misexpression of the constitutive RPGRex1-19 variant leads to severe photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2012;52:5189-5201.
17. Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype. Exp Eye Res. 2002;74:737-745.
18. Jacobson SG, Voigt WJ, Parel JM, et al. Automated light-and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986;93:1604-1611.
19. Roman AJ, Schwartz SB, Aleman TS, et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: darkadapted thresholds as outcome measures. Exp Eye Res. 2005; 80:259-272.
20. Araki K, Araki M, Miyazaki J, Vassalli P. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci U S A. 1995;92:160-164.
21. Shu X, Simpson JR, Hart A, et al. Functional characterization of the human RPGR proximal promoter. Invest Ophthalmol Vis Sci. 2012;53:3951-3958.
22. Aleman TS, Cideciyan AV, Aguirre GK, et al. Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model. Invest Ophthalmol Vis Sci. 2011; 52:6898-6910.
23. Huber G, Beck SC, Grimm C, et al. Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest Ophthalmol Vis Sci. 2009;50:5888-5895.
24. Knott EJ, Sheets KG, Zhou Y, Gordon WC, Bazan NG. Spatial correlation of mouse photoreceptor-RPE thickness between SD-OCT and histology. Exp Eye Res. 2011;92:155-160.
25. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci U S A. 2005;102:6177-6182.
26. Roman AJ, Boye SL, Aleman TS, et al. Electroretinographic analyses of RPE65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis. Mol Vis. 2007;13:1701-1710.
27. Cideciyan AV, Jacobson SG. An alternative phototransduction model for human rod and cone ERG a-waves: normal parameters and variation with age. Vision Res. 1996;36: 2609-2621.
28. Cideciyan AV. In vivo assessment of photoreceptor function in human diseases caused by photoreceptor-specific gene mutations. Methods Enzymol. 2000;316:611-626.
29. Aleman TS, LaVail MM, Montemayor R, et al. Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vision Res. 2001;41:2779-2797.
30. Lamb TD, Pugh EN Jr. Phototransduction, dark adaptation, and rhodopsin regeneration: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;47:5137-5152.
31. Kleinbaum DG, Kupper LL, Nizam A, Muller KE. Dummy Variables in Regression. Applied Regression Analysis and Other Multivariable Methods, 4th Ed. Belmont, CA: Duxbury Press; 2007:220.
32. Cheng H, Aleman TS, Cideciyan AV, Khanna R, Jacobson SG, Swaroop A. In vivo function of the orphan nuclear receptor NR2E3 in establishing photoreceptor identity during mammalian retinal development. Hum Mol Genet. 2006;15:2588-2602.
33. Cideciyan AV, Rachel RA, Aleman TS, et al. Cone photoreceptors are the main targets for gene therapy of NPHP5 (IQCB1) or NPHP6 (CEP290) blindness: generation of an all-cone Nphp6 hypomorph mouse that mimics the human retinal ciliopathy. Hum Mol Genet. 2011;20:1411-1423.
34. Lyubarsky AL, Falsini B, Pennesi ME, Valentini P, Pugh EN Jr. UV and midwave-sensitive cone-driven retinal responses of the mouse: a possible phenotype for coexpression of cone photopigments. J Neurosci. 1999;19:442-455.
35. Walia S, Fishman GA, Swaroop A, et al. Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene. Arch Ophthalmol. 2008;126:379-384.
36. Fishman GA, Farber MD, Derlacki DJ. X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol. 1988;106:369-375.
37. Sharon D, Sandberg MA, Rabe VW. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet. 2003;73:1131-1146.
38. Herrera W, Aleman TS, Cideciyan AV, et al. Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol Vis Sci. 2008;49:2651-2660.
39. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 1985;99:240-251.
40. Birch DG, Anderson JL, Fish GE. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 1999;106:258-268.
41. Iannaccone A, Kritchevsky SB, Ciccarelli ML, et al. Kinetics of visual field loss in Usher syndrome Type II. Invest Ophthalmol Vis Sci. 2004;45:784-792.
42. Cideciyan AV, Swider M, Aleman TS, et al. ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet. 2009;18:931-941.
43. Berson EL, Rosner B, Weigel-DiFranco C, Dryja TP, Sandberg MA. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci. 2002;43:3027-3036.
44. Hosch J, Lorenz B, Stieger K. RPGR: role in the photoreceptor cilium, human retinal disease, and gene therapy. Ophthalmic Genet. 2011;32:1-11.
45. Andréasson S, Breuer DK, Eksandh L, et al. Clinical studies of X-linked retinitis pigmentosa in three Swedish families with newly identified mutations in the RP2 and RPGR-ORF15 genes. Ophthalmic Genet. 2003;24:215-223.
46. Andréasson S, Ponjavic V, Abrahamson M, et al. Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene. Am J Ophthalmol. 1997;124:95-102.
47. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol. 2004;137:704-718.
48. Yagasaki K, Jacobson SG. Cone-rod dystrophy. Phenotypic diversity by retinal function testing. Arch Ophthalmol. 1989; 107:701-708.
49. Szamier RB, Berson EL, Klein R, Meyers S. Sex-linked retinitis pigmentosa: ultrastructure of photoreceptors and pigment epithelium. Invest Ophthalmol Vis Sci. 1979;18:145-160.
50. Massof RW, Finkelstein D. Vision threshold profiles in X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1979;18:426-429.
51. Demirci FY, Gupta N, Radak AL, et al. Histopathologic study of X-linked cone-rod dystrophy (CORDX1) caused by a mutation in the RPGR exon ORF15. Am J Ophthalmol. 2005;139:386-388.
52. Huang Y, Cideciyan AV, Papastergiou GI, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39:2405-2416.
53. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12:1073-1078.
54. Yang Z, Peachey NS, Moshfeghi DM, et al. Mutations in the RPGR gene cause X-linked cone dystrophy. Hum Mol Genet. 2002;11:605-611.
55. Jacobson SG, Aleman TS, Cideciyan AV, et al. Defining the residual vision in Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50:2368-2375.
56. Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci. 2007;48:4759-4765.
57. Thompson DA, Khan NW, Othman MI, et al. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15. PLoS One. 2012;7:e35865.
58. Hong DH, Pawlyk BS, Adamian M, Sandberg MA, Li T. A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo. Invest Ophthalmol Vis Sci. 2005;46:435-441.
59. Shu X, Zeng Z, Gautier P, et al. Zebrafish Rpgr is required for normal retinal development and plays a role in dynein-based retrograde transport processes. Hum Mol Genet. 2010;19: 657-670.